Genevieve Z. Steiner

ORCID: 0000-0002-8708-6104 · 12 papers in corpus
2025
·doi:10.2139/ssrn.5603451
2023
·doi:10.1016/j.ijpsycho.2023.05.097
observational 2023
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology ·doi:10.1016/j.clinph.2023.02.173

OBJECTIVE: Endometriosis is associated with neuroplastic changes in cognitive control and pain processing networks. This was the first study to assess eyes-closed resting electroencephalogram (EEG) oscillatory amplitudes in women with endom…

rct 2021
Journal of alternative and complementary medicine (New York, N.Y.) ·doi:10.1089/acm.2021.0004

Objective: To determine the acceptability and feasibility of acupuncture for the treatment of endometriosis-related chronic pelvic pain. Design: A prospective, randomized controlled feasibility study. Setting: Outpatient setting in Sydney, …

observational 2020
Frontiers in systems neuroscience ·doi:10.3389/fnsys.2020.593581

Endometriosis is a debilitating women's health condition and is the most common cause of chronic pelvic pain. Impaired cognitive control is common in chronic pain conditions, however, it has not yet been investigated in endometriosis. The a…

2019
·doi:10.1016/j.aimed.2019.03.013
2017
·doi:10.6084/m9.figshare.5181964

Treatment of endometriosis related chronic pelvic pain: study protocol v3. (DOCX 74 kb)

2017
·doi:10.6084/m9.figshare.5181964.v1

Treatment of endometriosis related chronic pelvic pain: study protocol v3. (DOCX 74 kb)

2017
·doi:10.6084/m9.figshare.5181970

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 120 kb)

2017
·doi:10.6084/m9.figshare.5181970.v1

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 120 kb)

2017
·doi:10.3389/conf.fnhum.2017.224.00040
other 2017
Pilot and feasibility studies ·doi:10.1186/s40814-017-0152-9

BACKGROUND: Endometriosis is the most common cause of chronic pelvic pain worldwide. Non-surgical treatments are effective for only 30-50% of women and have a significant side effect burden that leads to high discontinuation rates. Surgery …